{"id":"W2802999705","doi":"10.17925/usn.2018.14.1.47","title":"Edaravone in Amyotrophic Lateral Sclerosis’Lessons from the Clinical Development Program and the Importance of a Strategic Clinical Trial Design","year":2018,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Mitsubishi Tanabe Pharma Corporation; Mallinckrodt Pharmaceuticals","keywords":"Edaravone; Amyotrophic lateral sclerosis; Medicine; Clinical trial; Drug development; Clinical study design; Cohort; Disease; Intensive care medicine; Oncology; Pharmacology; Internal medicine; Drug","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007664571,0.0002656929,0.001421362,0.0000708942,0.00008355442,0.00002682106,0.0005201462,0.0002987389,0.0001496445],"category_scores_gemma":[0.001345644,0.0001335286,0.0001969727,0.000437983,0.002498907,0.00005069069,0.0003058719,0.001446365,0.00003722552],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002617222,"about_ca_system_score_gemma":0.0004346812,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001360418,"about_ca_topic_score_gemma":0.0005237524,"domain_scores_codex":[0.9912956,0.004486983,0.002543712,0.0007317046,0.0003755405,0.0005665118],"domain_scores_gemma":[0.9960711,0.002408485,0.0004573172,0.0008053667,0.0001081663,0.0001495864],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2012847,0.003236212,0.5484468,0.0001012719,0.0002364525,0.0002076097,0.0007027941,0.00000430578,0.000397488,0.001305292,0.002018686,0.2420584],"study_design_scores_gemma":[0.05048901,0.005241458,0.9363771,0.0002423171,0.00005797753,0.00001824522,0.000007839868,0.0007229832,0.000008654058,0.001554612,0.005135476,0.0001443017],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9711562,0.002869247,0.00001725603,0.02111565,0.0003517646,0.004370748,0.000003145465,0.00002300886,0.00009299596],"genre_scores_gemma":[0.9771484,0.01253267,0.002082619,0.007131101,0.0005526416,0.0005016488,0.000008444945,0.00002771474,0.00001475579],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3879304,"threshold_uncertainty_score":0.9207327,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4502577553450474,"score_gpt":0.4830974873236365,"score_spread":0.03283973197858914,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}